These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 10537248)

  • 21. Extent and structure of health insurance expenditures for complementary and alternative medicine in Swiss primary care.
    Busato A; Eichenberger R; Künzi B
    BMC Health Serv Res; 2006 Oct; 6():132. PubMed ID: 17032465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-cultural adaptation and validation of the Brazilian-Portuguese version of the Bath Ankylosing Spondylitis Functional Index (BASFI).
    Cusmanich KG; Kowalski SC; Gallinaro AL; Goldenstein-Schainberg C; Souza LA; Gonçalves CR
    Rev Bras Reumatol; 2012 Oct; 52(5):733-41. PubMed ID: 23090373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic results in ankylosing spondylitis (author's transl)].
    Salmhofer H
    Wien Klin Wochenschr Suppl; 1974; 28():12-5. PubMed ID: 4528346
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial.
    Bakker C; Hidding A; van der Linden S; van Doorslaer E
    J Rheumatol; 1994 Feb; 21(2):264-8. PubMed ID: 8182635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spondyloarthritis Research Consortium of Canada (SPARCC) enthesitis index in Turkish patients with ankylosing spondylitis: relationship with disease activity and quality of life.
    Zahiroglu Y; Ulus Y; Akyol Y; Tander B; Durmus D; Bilgici A; Kuru O
    Int J Rheum Dis; 2014 Feb; 17(2):173-80. PubMed ID: 24576273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement.
    Rejón E; Giménez MD; Mayordomo L; Rodríguez S; González MP; Marenco JL
    Scand J Rheumatol; 2004; 33(5):323-6. PubMed ID: 15513681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutting costs of medical claims by identifying excesses in service per illness, costs per service.
    Employee Benefit Plan Rev; 1984 Apr; 38(10):7-8. PubMed ID: 10266111
    [No Abstract]   [Full Text] [Related]  

  • 29. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iatrogenic fractures in ankylosing spondylitis--a report of two cases.
    Ruf M; Rehm S; Poeckler-Schoeniger C; Merk HR; Harms J
    Eur Spine J; 2006 Jan; 15(1):100-4. PubMed ID: 16032433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ankylosing spondylitis: a dual perspective of current issues and challenges.
    Khan MA
    J Rheumatol Suppl; 2006 Sep; 78():1-3. PubMed ID: 17042054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect(s) of a six-week home-based exercise program on the respiratory muscle and functional status in ankylosing spondylitis.
    Ortancil O; Sarikaya S; Sapmaz P; Basaran A; Ozdolap S
    J Clin Rheumatol; 2009 Mar; 15(2):68-70. PubMed ID: 19265348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fetuin-A and interleukin-18 levels in ankylosing spondylitis.
    Sari I; Kebapcilar L; Taylan A; Bilgir O; Kozaci DL; Yildiz Y; Yuksel A; Gunay N; Akkoc N
    Int J Rheum Dis; 2010 Feb; 13(1):75-81. PubMed ID: 20374388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retained and discontinued conventional and unconventional measures by patients with Bechterew disease for modifying the course of illness].
    Falkenbach A; Toennemann J; Mur E
    Z Rheumatol; 2002 Jun; 61(3):271-8. PubMed ID: 12219631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a multimodal exercise program for people with ankylosing spondylitis.
    Ince G; Sarpel T; Durgun B; Erdogan S
    Phys Ther; 2006 Jul; 86(7):924-35. PubMed ID: 16813473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.
    Widberg K; Karimi H; Hafström I
    Clin Rehabil; 2009 Jul; 23(7):599-608. PubMed ID: 19403551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unconventional medicine in Central Europe: a misuse of public health insurance?
    Falkenbach A; Herold M
    J Altern Complement Med; 1999 Oct; 5(5):479-81. PubMed ID: 10537248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of conventional and unconventional therapies among patients with ankylosing spondylitis].
    Curda B; Luxl M; Glauninger P; Falkenbach A
    Forsch Komplementarmed Klass Naturheilkd; 2000 Apr; 7(2):85-8. PubMed ID: 10899745
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.